A persistent sciatic artery (PSA) is very rare congenital vascular anomaly which is present in 0.025% to 0.04% of the population by an angiographic study. A PSA is usually combined with aneurismal disease or thromboembolic events because of its arteriosclerosis and vessel wall degeneration. The treatments of symptomatic PSA are comprised of exclusion of PSA from circulation and bypass surgery for the lower limb. However, surgical treatment should be tailored to its anatomy and presentation. We report a successful treatment of PSA with distal thromboembolism by thromboembolectomy without bypass surgery. (Fig. 2) . He was discharged 7 days after the operation and took aspirin and warfarin. However, he readmitted for recurrence of left claudication 6 months later. The finding in CT angiogram was similar to the preoperative one
CASE REPORT
A 61-year-old man, with no previous history of trauma, was referred to Ewha Womans University Mokdong Hospital for further evaluation of left claudication which was appeared a month prior to admission. On physical examination, absence of pulsation at left dorsalis pedis was noted with relatively intact pulsation at left popliteal artery and left femoral artery. His past medical history was unremarkable. A computed tomography (CT) angiogram ( Fig. 1 ), performed to evaluate the whole vascular bed of lower extremity, revealed the presence of complete persistent sciatic artery (PSA) with incompletely developed superficial femoral artery (SFA) (type 2A persistent sciatic artery), and the complete obstruction of distal popliteal artery by thrombus was also noted. Despite of the complete obstruction of the distal portion, patency from internal iliac artery to proximal portion of popliteal artery through the PSA was relatively preserved. With neither tortuous feature nor aneurysmal change in PSA, we decided to perform thromboembolectomy only. Elective thromboembolectomy for distal popliteal arterial thrombosis was performed.
The patient was placed in prone position and a vertical incision was made over the popliteal fossa. Exposure of the popliteal artery was followed by arteriotomy and distal embolectomy using a Fogarty catheter. A considerable amount of fresh red and old organized thrombus was removed. Although mild calcification of arterial wall was found, another bypass surgery was not considered because of the relatively good arterial bed. Patient made uneventful recovery and postoperative follow-up CT angiogram showed no residual thrombus in popliteal artery (Fig. 2) . He was discharged 7 days after the operation and took aspirin and warfarin. However, he read- without any interval aggravation of arteriosclerosis or aneurysmal change (Fig. 3) . Thromboembolectomy was performed again and the intraoperative findings were unremarkable to previous one. The postoperative recovery was uneventful and discharged without any complications. During the 6-year follow-up period, he was supposed to take aspirin and warfarin for 3 years and aspirin only after that. And there was no recurrence of thromboembolism or complications including aneurysmal formation.
DISCUSSION
The sciatic artery, a branch of umbilical artery, is the main arterial supply of the developing lower limb during 6 mm stage of embryonic development [1, 2] . With the development of femoral artery from the external iliac artery, the sciatic artery regresses with time [1] [2] [3] [4] [5] . The PSA originated from the failure of sciatic arterial involution process, with low incidence of between 0.025% and 0.04% [1, [3] [4] [5] . The anomaly of this process determines the types of PSA from the incomplete type to complete type with relative hypoplastic femoral artery [2, 6] . Pillet et al. [7, 8] By eliminating complicated operative procedures for exclusion of PSA and bypass, lots of complications including damage to sciatic nerve can be avoided.
In conclusion, Treatment of symptomatic PSA should be tailored to its anatomy and presentations and thromboembolectomy without bypass surgery should be considered as one of strategies in the treatment of symptomatic PSA.
